We're not the expert in this field and we teamed up with the best company in the world to develop tumor-infiltrating lymphocytes, and I believe that Iovance is about to solve the problem they have into like this quality stuff. I'll leave it to the Iovance team to answer this question, but also recently in NK cells that are derived from iPS cells, CAR T-cell and KCAR -- CARs that are going to be developed by Cytovia. So we're also very excited about it.